Archivio istituzionale della ricerca dell'Università degli Studi di Palermo
IRIS è il sistema di gestione integrata dei dati della ricerca (persone, pubblicazioni, progetti, attività) adottato dall’Università di Palermo, e ha lo scopo di raccogliere, conservare, documentare, e diffondere ad accesso aperto le informazioni relative alla produzione scientifica degli autori afferenti all’Ateneo.
EnglishPhosphatase PTP1B has become a therapeutic target for the treatment of type 2-diabetes, whereas recent studies have revealed that PTP1B plays a pivotal role in pathophysiology and development of breast cancer. Oleuropein is a natural, phenolic compound with anticancer activity. The aim of this study was to address the question whether PTP1B constitutes a target for oleuropein in breast cancer MCF-7 cells. The cellular MCF-7 breast cancer model was used in the study. The experiments were performed using cellular viability tests, Elisa assays, immunoprecipitation, flow cytometry analyses and computer modelling. Herein, we evidenced that the reduced activity of phosphatase PTP1B after treatment with oleuropein is strictly correlated with decreased MCF-7 cellular viability and cell cycle arrest. These results provide new insight into further research on oleuropein and possible role of the compound in adjuvant treatment of breast cancer
Przychodzen, P., Kuban-Jankowska, A., Wyszkowska, R., Barone, G., Lo Bosco, G., Lo Celso, F., et al. (2019). PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model. TOXICOLOGY IN VITRO, 61(2019), 1-9.
| Data di pubblicazione: | 2019 | |
| Titolo: | PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model | |
| Autori: | ||
| Citazione: | Przychodzen, P., Kuban-Jankowska, A., Wyszkowska, R., Barone, G., Lo Bosco, G., Lo Celso, F., et al. (2019). PTP1B phosphatase as a novel target of oleuropein activity in MCF-7 breast cancer model. TOXICOLOGY IN VITRO, 61(2019), 1-9. | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1016/j.tiv.2019.104624 | |
| Abstract: | Phosphatase PTP1B has become a therapeutic target for the treatment of type 2-diabetes, whereas recent studies have revealed that PTP1B plays a pivotal role in pathophysiology and development of breast cancer. Oleuropein is a natural, phenolic compound with anticancer activity. The aim of this study was to address the question whether PTP1B constitutes a target for oleuropein in breast cancer MCF-7 cells. The cellular MCF-7 breast cancer model was used in the study. The experiments were performed using cellular viability tests, Elisa assays, immunoprecipitation, flow cytometry analyses and computer modelling. Herein, we evidenced that the reduced activity of phosphatase PTP1B after treatment with oleuropein is strictly correlated with decreased MCF-7 cellular viability and cell cycle arrest. These results provide new insight into further research on oleuropein and possible role of the compound in adjuvant treatment of breast cancer | |
| Settore Scientifico Disciplinare: | Settore CHIM/02 - Chimica Fisica Settore CHIM/03 - Chimica Generale E Inorganica Settore BIO/14 - Farmacologia | |
| Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
| File | Descrizione | Tipologia | Licenza | |
|---|---|---|---|---|
| 1-s2.0-S0887233319304564-main.pdf | Versione Editoriale | Administrator Richiedi una copia |
Copyright © 2021